Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with IbrutinibRituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912 Pophali, P. A., Wang, X., Zhao, F., Kay, N. E., Hanson, C. A., Thomas, M. L., O'Brien, S. M., Barrientos, J., Paietta, E. M., Leis, J. F., Zhang, C., Coutre, S., Barr, P. M., Cashen, A., Mato, A. R., Singh, A., Little, R. F., Erba, H. P., Stone, R. M., Litzow, M. R., Tallman, M. S., Shanafelt, T., Wagner, L. I. AMER SOC HEMATOLOGY. 2021

View details for DOI 10.1182/blood-2021-150462

View details for Web of Science ID 000736398806032